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A COMPARATIVE ANALYSIS OF SELECTED ASPECTS
OF PATENT LAW IN CHINA AND THE UNITED STATES
Louis S. SorellW
Abstract: China's recent admission to the World Trade Organization will bring
increased attention to China's patent law, especially as foreign companies expand their
technology-based presence in China. This Article summarizes the development of patent
law in the United States and China, and compares various aspects of Chinese and
American patent law. These aspects include the administrative and judicial hierarchy of
the American and Chinese patent systems, patentability requirements, infringement and
validity issues, the availability of injunctive relief, and the determination of monetary
damages. The Article also discusses the compulsory licensing provisions of China's
patent law. Similarities and differences of each patent system are also discussed.
I. INTRODUCTION
The foundations of patent law in the United States predate the
founding of the republic.' In contrast, the concept of patent law in the
People's Republic of China was not recognized until 1950.2 Nevertheless,
as China evolves from a planned economy towards a "socialist market
economy,",3 its patent law must mature to conform to the standards of the
global economy.4 This Article briefly reviews the development of patent
law in both the United States and China, compares important features of the
two systems, and describes some recent substantive revisions in China's
patent law. 5
t Partner, Baker Botts L.L.P. (New York, NY). Any views expressed in this article are only the
author's then-present views, which should not be attributed to the firm or any of its clients.
See generally H. Forman, Two Hundred Years ofAmerican Patent Law, in 200 YEARS OF ENGLISH
& AMERICAN PATENT, TRADEMARK & COPYRIGHT LAW, 21, 25-27 (1976).
2 See generally L. Harrington, Recent Amendments to China's Patent Law: The Emperor's New
Clothes?, 17 B.C. INT'L & COMP. L. REV. 337, 342-48 (1994).
See Hu Zuochao, The Commercialization and Evaluation of Intellectual Property Rights, Address
at the Mainland-Hong Kong Special Administrative Region (HKSAR) Intellectual Property Symposium, at
www.cpo.cn.net/english/meeting/200hk/eO9-I.htm (Apr. 14, 2000).
4 China was admitted to the WTO on November 10, 2001. Joseph Kahn, World Trade Organization
Admits China, Amid Doubts, N.Y. TIMES, Nov. 11, 2001, at A16.
5 Interview with Mr. Kan Zu, Partner, Beijing Unitalen Patent & Trademark Law, in New York,
NY. (Spring 2001).
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II. THE DEVELOPMENT OF PATENT LAW IN THE UNITED STATES AND
CHINA
Prior to the establishment of the United States, the colonial
governments enacted laws to establish or stimulate industries by awarding
exclusive grants.6 However, unlike the prior English "patents of invention,"
which were royal grants and favors, colonial patent laws were specific grants
7to individual inventors. In 1641 Massachusetts adopted what many
consider to be the first general patent statute in America, and other states
soon followed.8 However, by 1787 it was clear that, in view of overlapping
state patents, a centralized patent system was desirable.9 Ultimately, this
desire manifested itself in the United States Constitution, which states that:
The Congress shall have Power ... to promote the Progress of
Science and useful Arts, by securing for limited Times to
Authors and Inventors the exclusive Right to their respective
Writings and Discoveries. 
1 0
The first American patent statute was subsequently enacted in 1790.
Significant amendments and improvements were made in 1836, 1861, and
1952.11 Additional important amendments to American patent law occurred
in 199412 and 1999.13
The Constitution of the People's Republic of China also recognizes
the importance of inventions:
The state promotes the development of the natural and social
sciences, disseminates scientific and technical knowledge, and
6 See Forman, supra note 1, at 25-27.
7 See id.
s See id.
See id. at 25-26.
1O U.S. CONST. art. I, § 8, cl. 8.
I See generally Forman, supra note 1, at 28-30.
2 In 1994, the Uruguay Round Agreements Act ("URAA"), 35 U.S.C. § 154 (1994), implemented
the participation of the United States in the Uruguay Round of the General Agreement on Tariffs and Trade
("GATT"). The URAA was enacted to harmonize the term provisions of U.S. patent law with our leading
trading partners (e.g., Europe and Japan), and extended the terms of U.S. patents in force on June 8, 1995 to
the greater of: (i) seventeen years from the date of patent issuance; or (ii) twenty years from the filing date
of the patent application from which the patent issued. See § 154(c)(1). For U.S. patent applications filed
or issued after June 8, 1995, the patent term is twenty years from the date of filing of the patent applidation.
See § 154 (a)(2).
13 See American Inventors Protection Act of 1999, Pub. L. No. 106-113, 113 Stat. 1501 (1999).
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commends and rewards achievements in scientific research as
well as technological discoveries and inventions.
14
Modem Chinese patent law began with the issuance of the
"Provisional Regulations on the Protection of the Invention Right and the
Patent Right" in 1950. Although these regulations and subsequent enabling
rules promulgated in 1963 provided modest rewards to inventors, state
ownership of novel inventions was mandated. 15  Moreover, during the
Cultural Revolution from 1966-1975, even these small awards and
incentives were eliminated.' 6  Only after the overthrow of the "Gang of
Four" in 1976 and the establishment of the "Four Modernizations" of (i)
development of industry, (ii) agriculture, (iii) science and technology, and
(iv) national defense, did China's leadership begin to encourage economic
and industrial development.17 As a result, between 1980 and 1983, China
sent envoys with legal, scientific, and political backgrounds abroad to study
the patent laws and practices of various developed nations including the
United States, Canada, and various European countries.'
8
In 1984, China enacted a basic patent law based on the information
obtained from various foreign countries.' 9 Nevertheless, "complaints by
U.S. patentees and other foreign patent holders of piracy and infringement
by the Chinese continued through the 1980,s.,,20 After threats of sanctions
by the United States Trade Representative ("USTR"), China agreed to
revamp its intellectual property protection, and signed a Memorandum of
Understanding on the protection of intellectual property with the United
14 XIANFA [Constitution] art. 20 (1993) (P.R.C.).
Harrington, supra note 2, at 342 & n.32.
6 d. at 342.
I d. at 343 & n.35.
's Id. at 345 n.52.
19 Zhonghua Remin Gongheguo Zhuanli Fa [Patent Law of the People's Republic of China] (1984),
translated in Charles D. Paglee, Chinalaw Web-PRC Patent Law, at http://www.qis.net/-chinalaw/
prclawl07.htm (last modified May 1, 1998). The 1984 Patent Law was adopted at the Fourth Session of
the Study Committee of the Sixth National People's Congress on March 12, 1984, and became effective on
April 1, 1985. Id.
20 Harrington, supra note 2, at 345 (footnote omitted).
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States in 1992.21 China's patent law was thereafter amended in 1992,22 and
implementing regulations were also adopted.23
The 1992 amendments made several important reforms, including:
" Expanding the technological fields of patent protection to include
pharmaceutical products, foods, beverages, flavorings, and
substances obtained via a chemical process.
" Extending the duration of patent rights for inventions from fifteen
to twenty years, and extending the duration of patent rights for
utility models and designs from five to ten years.
" Narrowing the grounds under which a compulsory license may be
granted.
* Replacing the pre-grant opposition procedure (typical in European
patent practice) with a post-granting revocation procedure, thereby
shortening the patent approval process.
24
The 1992 amendments generated mixed reviews. One commentator
has observed that, on balance, the 1992 amendments were expected to
"allow investors to act with more confidence in the turbulent waters of
China's burgeoning commercial markets., 25 However, another commentator
has taken a less optimistic view, observing that China's patent law "cannot
be that significant without some breakthrough in both economic and legal
21 See id. at 371-74.
22 The 1992 amendments were adopted by the Gyanyu Xiugai Zhonghua Remin Gungheguo Zhuanli
Fa De Jueding [Decision Regarding the Revision of the Patent Law of the People's Republic of China]
(adopted at the twenty-seventh Session of the Standing Committee of the Seventh National People's
Congress on Sept. 4, 1992). These amendments are discussed in detail in Harrington, supra note 2, at 359-
69 23 See Zhong Hua Ren Min Gong He Guo Zhuan Li Fa Shi Shi Xi Ze [Implementing Regulations for
the Patent Law of the People's Republic of China], translated in Charles D. Paglee, Chinalaw Web-
Implementing Regulations for the Patent Law, at http://www.qis.net/chinalaw/prclawl08.htm (last
modified May 1, 1998). These regulations were promulgated by China's Patent Office on December 21,
1992.24 See Yin Xintian, A Brief Introduction to the Patent Practice in China, 9 DUKE J. COMP. & INT'L
LAW 253 (1998). Several of the 1992 amendments were made to reconcile China's patent law with the
Agreement on Trade-Related Aspects of Intellectual Property Rights ("TRIPS"). For example, prior to the
1992 amendments, pharmaceutical products were not patentable under China's patent law. See State
Intellectual Property Office of the P.R.C., Differences Between Chinese Patent Law and TRIPS Agreement,
at http://www.cpo.cn.net/english/meeting/2000kh/e01-1.htm (last visited Feb. 6, 2002). For a more
specific discussion of administrative protection of pharmaceutical products in China, see Gao Xia-Yun, An
Introduction to Administrative Protection for Pharmaceuticals, 9 DUKE J. COMP. & INT'L L. 259 (1998).
25 Harrington, supra note 2, at 370.
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reforms," while also concluding that "reforms have been leading China to a
market economy ruled by law, suggesting a significant patent law.",
26
Most recently, on August 25, 2000 China finalized the second revision
of its patent law.27 These revisions were approved by the National People's
Congress, and took effect on July 1, 2001.28 These revisions are intended to
further the following principles:
* Accommodation of the socialist market economy.
* Strengthening the protection of patent rights.
" Simplification and acceleration of patent approval.
" Harmonizing China's patent law with international standards
and treaties.2 9
III. PATENTABILITY REQUIREMENTS IN THE UNITED STATES AND CHINA
A. Patentability Requirements in the United States
American patent law permits the granting of three types of patents:
i.e., utility patents, design patents, and plant patents. Utility patents are
directed to inventions that are a "process, machine, manufacture, or
composition of matter, or any new and useful improvement thereof.
30
Utility patents cover inventions most people are familiar with: e.g.,
computers, electronics, machines, chemicals and pharmaceuticals. Design
patents are directed to a "new, original, and ornamental design for an article
of manufacture.",31 Plant patents are directed to a distinct and new variety of
plant which has been asexually reproduced, other than "a tuber propagated
plant or a plant found in an uncultivated state. 32 Utility and plant patents
26 Liwei Wang, The Current Economic and Legal Problems Behind China's Patent Law, 12 TEMPLE
INT'L & COM. L.J. 1, 41-42 (1998).
27 This revision was made by the Gyanyu Xiugai Zhonghua Remin Gungheguo Zhuanli Fa De
Jueding [Decision Regarding the Revision of the Patent Law of the People's Republic of China] (adopted at
the Seventeenth Session of the Standing Committee of the Ninth National People's Congress on August 25,
2000). See Patent Office of the P.R.C., Proclamation No. 78, Transitional Measures for the
Implementation of the Revised Patent Law and its Implementing Regulations, at http://www.cpahldtd.com/
Publications/Laws/Proclamation-78.html (June 25, 2001).
2s See Sino-US. Intellectual Property Symposium Held in Beiing, 2 CHINA INTELL. PROP. NEWSL.
(Xinhua News Agency), at http://www.lehmanlaw.com/newsletter/ip/archives/20
0 10 3 14 .htm (Mar. 14,
2001) (discussing important portions of these revisions).
29 Statement of Mr. Ma Lianyuan, Deputy Commissioner of State Intellectual Property Office of the
P.R.C., delivered at the National Patent Work Conference (Jan. 18, 2001) (on file with author).
3 35 U.S.C. § 101 (1994).
31 § 171.
32 § 161.
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have a basic term of twenty years from the filing date of the corresponding
patent application; 33 however, design patents have a term of fourteen years
from the date of grant of the design patent.34
To obtain a United States patent for an invention, the invention must
meet the following criteria:
* The invention must be directed to "patentable subject matter," i.e.,
a new and useful process, machine, manufacture or composition of
matter, or a new and useful improvement thereof.
35
" The invention must be "novel." Unlike most other countries
(including China), the United States has a "first-to-invent" rather
than a "first-to-file" patent system. 6 The types of "prior art"
which can defeat the novelty of an invention include: (i) a
description of the invention in a printed publication anywhere in
the world prior to the invention by the applicant or more than one
year prior to the filing date of the United States patent
application; 37 (ii) public knowledge or use in the United States of
the invention prior to the invention by the applicant or more than
one year prior to the filing date of the United States patent
application; 38 (iii) an offer for sale or sale of the invention in the
United States more than one year prior to the filing date of the
United States patent application; 39 and (iv) a description of the
invention in another United States patent having a filing date
earlier than the date of the applicant's invention.40 In addition, the
inventor's rights to a patent are forfeited if the invention was
abandoned prior to the filing of a patent application; 41 was
invented by someone other than those named on the patent
application;42 or was first made by someone else anywhere in the
world, and the prior invention was not abandoned, suppressed or
concealed.43
33 § 154(a)(2); see also § 161.
" § 173.
31 § 101.
36 See Paulik v. Rizkalla, 760 F.2d 1270 (Fed. Cir. 1985).
7 35 U.S.C. § 102(a), (b) (1994).
§ 102(a), (b).
39 § 102(b).
40 § 102(e).
41 § 102(c).
42 § 102(0.
43 § 102(g).
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" The invention must be "nonobvious" to one of ordinary skill in the
relevant technical field or "art" in view of the prior art."
* The patent application describing the invention must contain an
adequate written description of the invention, and the means and
process of making and using the invention. The description must
also be sufficient to enable a person of ordinary skill in the art to
make and use the invention, and must disclose what the inventor
considered the "best mode" of carrying out the invention.4 5
" The patent application must claim the invention with one or more
"claims" which "particularly point out and distinctly claim" the
subject matter of the invention. 6
B. Patentability Requirements in China
China's current patent law 4 7 permits the granting of a patent for three
types of "inventions-creations." These are "inventions," "utility models,"
and "designs." 48  "Inventions" correspond to what American patent
practitioners would consider "utility" patents, whereas "utility models"
correspond to "improvement" patents, which fall within the umbrella of
utility patents under U.S. patent law.49  "Design" patents are roughly
equivalent in both countries.50 Invention patents have a term of twenty years
from the filing date of the patent application, whereas utility model and
51design patents have a term often years.
Unlike American patent law, in which the inventor initially owns all
rights irrespective of the type of invention,52 China's patent law
distinguishes between "service" and "non-service" inventions. A "service"
44 § 103 (1994).
45 § 112. Although these requirements are all contained in the same (first) paragraph of Section 112,
they are independent requirements commonly referred to as the "written description," "enablement," and
"best mode" requirements.
16 § 112, para. 2. This is commonly referred to as the "definiteness" requirement.
47 See Zhonghua Remin Gongheguo Zhuanli Fa (Patent Law of the People's Republic of China]
(2000), [hereinafter China's Patent Law ("CPL")], translated in http://www.san-you.com/en/
list.asp?id=163&df=2 (last modified Jan. 8, 2002). CPL was amended for the second time by the Decision
Regarding the Revision of the Patent Law of the People's Republic of China, adopted at the Seventeenth
Session of the Study Committee of the Ninth National People's Congress on August 25, 2000. Id.
46 Id. art. 2.
Interview with Kan Zu, supra note 5; see also Harrington, supra note 2, at 347 n.66 (describing
utility models as "minor technical and production improvements").
50 Interview with Kan Zu, supra note 5.
"1 CPL, supra note 47, art. 42.
11 35 U.S.C. § 261 (1994) (providing that U.S. patents have the attributes of personal property, and
are assignable in law by an instrument in writing).
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invention is one made by an inventor in execution of tasks for the entity
employing the inventor, or made by the inventor mainly using the material
and technical means of the employer. Patent rights for service inventions
belong to the controlling entity. Conversely, patent rights for non-service
inventions vest in the inventor. 53
Under China's patent law there are three requirements for
patentability:
" Novelty-Before the filing date of the patent application, no identical
invention or utility model has been publicly disclosed in publications
anywhere or has been publicly used or made known to the public by
any other means in China, nor has any other person filed a patent
application in China which described the invention or utility model
where the patent application was published after the filing date of the
inventor's patent application. 4  This prerequisite is analogous
(although not identical) to the novelty requirement under American
patent law," although the critical date here is the filing date of the
application, consistent with China's status as a "first-to-file"
country.
5 6
* Inventiveness-The invention must have prominent substantive
features and represent a notable improvement compared with the
technology existing before the filing date of the patent application. If
the patent application is for a utility model, it must have substantive
features and represent an improvement. 57  This prerequisite is
analogous to the nonobviousness requirement under American patent
law.58
" Practical Applicability--An invention or utility model must be
capable of being made or used and producing effective results." This
corresponds to the utility requirement of American patent law.
60
For design patents, the design may not be identical or similar to any
other design which has been publicly disclosed anywhere or publicly used in
China, and additionally cannot "be in conflict with any legal prior rights
53 CPL, supra note 47, art. 6.
s' Id. art. 22.
s See 35 U.S.C. § 102.
56 CPL, supra note 47, art. 9.
57 Id. art. 22.
58 See 35 U.S.C. § 103.
59 CPL, supra note 47, art. 22.
6o See 35 U.S.C. § 101.
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obtained by any other person."61  The precise meaning of this latter
provision is unclear from the statutory language. However, practitioners in
China have observed that this language (which was added in the most recent
revisions to China's patent law) aims to prevent conflicts with prior
copyright and trademark rights, which are intended to preempt subsequent
design patent protection.62
A grace period exists to prevent certain acts from barring patentability
if these acts occur within six months prior to the filing date of a patent
application.63 Analogous grace periods exist under American patent law,
although the grace periods are for one year rather than six months.
64
An important distinction between American and Chinese patentability
standards is that China's patent law specifically precludes patentability for
certain inventions clearly patentable under American law, such as "plant
varieties" and "methods for the diagnosis or for the treatment of diseases."
65
Another important distinction is that only "invention" patent applications are
substantively examined under China's patent law.66  A request for
substantive examination of an invention patent application must be made
within three years of the application filing date.67 Thus, patent applications
for utility models and designs are only preliminarily examined for
administrative and procedural conformity. If these standards are met, the
design or utility patent will be granted without substantive examination.68
The administrative procedures available for an applicant dissatisfied
with the initial substantive examination of a patent application are similar in
the United States and China. In the United States, an applicant dissatisfied
with the results of the examination of a patent application may appeal to the
United States Patent and Trademark Office's Board of Patent Appeals and
Interferences ("BPAI"). 69 The decision of the BPAI may be appealed to the
United States Court of Appeals for the Federal Circuit70 and ultimately to the
United States Supreme Court,71 although this rarely occurs.
61 CPL, supra note 47, art. 23.
62 See The Outline of the Revised Patent Law, CPA NEWSLETTER, at http://www.cpahkltd.com/
Newsletter/RevPLaw.htmi (last visited Mar. 5, 2002).
63 CPL, supra note 47, art. 24.
" See 35 U.S.C. § 102(b) (providing a one-year grace period for certain acts, i.e., offers for sale,
sales and publication, which would otherwise preclude patentability).
65 CPL, supra note 47, art. 25.
66 CPL, supra note 47, arts. 35, 40; Interview with Kan Zu, supra note 5.
67 CPL, supra note 47, art. 35.
61 Id. art. 40.
69 35 U.S.C. § 134.
71 § 141.
71 28 U.S.C. § 1254(1) (1994).
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In China, an applicant dissatisfied with the substantive examination of
an invention patent application may seek reexamination by the Patent
Reexamination Board ("PRB").72 If the applicant is dissatisfied with the
PRB's decision, legal proceedings may be instituted in the People's Court.73
Subsequent judicial appeals may be taken to the intermediate court of a city
or province, and at least theoretically to the People's Supreme Court,
74
although such an appeal is extremely rare.
From an administrative perspective, it appears that China's patent law
and practice conforms to international norms. China became a member state
of the Paris Convention for the Protection of Industrial Property in 1985 and
of the Patent Cooperation Treaty ("PCT") as of January 1, 1994.75 However,
the number of invention patent applications filed by and granted to Chinese
applicants is comparatively small. Furthermore, foreign enterprises hold
many Chinese patents in high-technology fields.76
IV. ENFORCEMENT ISSUES REGARDING PATENTS IN CHINA
A. Patent Infringement Issues
A person who makes, uses, offers to sell, or sells an invention
patented in the United States, without authority, infringes the patent.
77
Similarly, under China's patent law, exploitation of a patent without the
patentee's authorization constitutes infringement. 78  However, there are
significant differences regarding both the procedural and substantive aspects
of patent infringement litigation in the United States and China. For
example, in the United States, federal courts have exclusive jurisdiction over
patent infringement suits. 79  In contrast, a patent infringement action in
72 CPL, supra note 47, art. 41.
73 Id.
74 Interview with Kan Zu, supra note 5.
75 See State Information Office of the Council of the P.R.C., Intellectual Property Protection in
China, at http://www.english.peopledaily.com.cn/whitepaper/9.html (June 1994); see also Xintian, supra
note 24, at 255.
76 Xu Yiping, Patent and Design Protection Versus Small and Medium Size Enterprises in China,
Address at the Mainland-HKSAR Intellectual Property Symposium (2000), at http://www.cpo.cn.net/
english/meeting/2000hk/e05-1.htm (last visited Feb. 6, 2002).
7 35 U.S.C. § 271(a) (Supp. V 1999).
78 CPL, supra note 47, art. 57. "Exploitation" means the making, using, offering to sell, selling or
importing of a patented product, or using a patented process or use, or offering to sell, selling or importing
the product obtained directly by the patented process, for production or business purposes. Id. art. 11.
'9 See 28 U.S.C. § 1338(a) (Supp. V 1999) (conferring patent jurisdiction on the federal district
courts); 28 U.S.C. § 1259(a) (Supp. V 1999) (conferring exclusive jurisdiction of all appeals in patent cases
in the district courts to the U.S. Court of Appeals for the Federal Circuit).
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China may be filed in the People's Court, or a request may be made to "the
authorities for patent work" to administratively resolve the infringement
issue.
80
This administrative procedure has no counterpart in American patent
law. If the administrative route is chosen, the request is made to the patent
administrative office having jurisdiction over the matter. An administrative
authority for patent affairs is established in every province, autonomous
region, and municipality.8' The patent administrative office has the power to
enjoin acts of infringement and may mediate the damages issue upon the
request of the parties.82 If mediation is unsuccessful, a lawsuit may be
initiated in the People's Court in accordance with China's Civil Procedure
Law. 83  There are tactical advantages in using the administrative route to
establish infringement: namely, the administrative procedure is faster and
the administrative decision of infringement may be used as evidence of
infringement in a subsequent judicial proceeding. 84 However, as a practical
matter, the issue of damages may be difficult to resolve using the
administrative route.85
Under both American and Chinese patent law, determination of
infringement requires a comparison of the plaintiffs patent claims and the
accused product or process. Accordingly, interpretation of patent scope is
the first step in an analysis of alleged infringement.
In the United States, the interpretation or construction of a patent
claim is a question of law resolved by the judge, even if the patent
infringement case will ultimately be tried to a jury.86  Once the proper
meaning of the claims has been determined, infringement may be found in
either one of two ways: literal infringement or infringement under the
doctrine of equivalents. Literal infringement requires that every feature or
"element" of the patent claim be found in the accused product or process. 87
The judge may use "intrinsic" evidence such as the patent claim language,
the patent description or "specification," as well as the "prosecution history"
(i.e., the documents generated during the patent application process) to
determine the meaning and scope of the claims. Additional "extrinsic"
8o CPL, supra note 47, art. 57.
"I Interview with Kan Zu, supra note 5; see also Xintian, supra note 24, at 256.
82 CPL, supra note 47, art. 57.
83 id.
81 Interview with Kan Zu, supra note 5.
85 Id.
'6 Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996).
87 Amhil Enterprises, Ltd. v. Wawa, Inc., 81 F.3d 1554, 1562 (Fed. Cir. 1996).
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evidence such as the testimony of technical experts may be also used by the
judge to resolve ambiguities in the meaning of terms in the claims.88
Infringement under the doctrine of equivalents may be found even if
the accused product or process does not contain each limitation of the claim,
but the accused product or process must contain a feature "equivalent" to the
missing claim limitation. W An "equivalent" feature is one that is
insubstantially different than the corresponding element required by the
patent's claim.90 However, the scope of equivalency is not unlimited: for
example, the doctrine of "prosecution history estoppel" prevents thepatentee
from regaining aspects of the claimed invention that were relinquished
during the "prosecution" of the patent application during the examination
process before the U.S. Patent and Trademark Office. 91 It is important to
note that the substantive body of American patent law regarding claim
interpretation and infringement analysis (both literal and under the doctrine
of equivalents) has evolved from case law: the American patent statute is
silent on this issue, and simply states that infringement occurs if a person,
without authority, "makes, uses, offers to sell or sells any patented invention,
within the United States, or imports into the United States any patented
invention" during the term of the patent.
92
In contrast, China's patent law specifically states that "[t]he extent of
protection of the patent right for invention or utility model shall be
determined by the terms of the [patent's] claims. The description and the
appended drawings may be used to interpret the claims., 93 However, it is
unclear whether this provision distinguishes between literal infringement
and infringement under the doctrine of equivalents. As Justice Jiang Zhipei
recently queried:
[In] a patent infringement litigation, how is the judge to define
the scope of protection? Should the principles of equivalence
be applied, and to what extent? How do we judge the
infringing conduct? How do we conduct and evaluate a
technical appraisal to solve the dispute on technology between
88 Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996).
89 Warner-Jenkinson Co. v. Hilton Davis Chem. Co., 520 U.S. 17, 40 (1997).
90 Id.
9' Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 56 U.S.P.Q.2d 1865"(Fed. Cir. 2000),
cert. granted, 69 U.S.L.W. 3779 (U.S. June 18, 2001) (No. 00-1543). The Festo decision has significantly
narrowed the usefulness of the doctrine of equivalents for patentees, although it is unclear at present
whether the U.S. Supreme Court will adopt the limitations on the doctrine of equivalents set forth by the
federal circuit in Festo.
" 35 U.S.C. § 271(a) (Supp. V 1999).
93 CPL, supra note 47, art. 56.
VOL. I I No. 2
PA TENT LAW IN CHINA AND THE US.
the parties concerned? How do we calculate the damages of
patent infringement? Chinese judges need to solve these
problems urgently.
94
However, Justice Cheng Yongshun recently commented that both the
principles of estoppel and the doctrine of equivalents may be used in
defining the scope of a patent. 95 Justice Yongshun's comments highlight
two fundamental problems encountered in attempting to view China's patent
law using American patent law principles such as claim construction and the
doctrine of equivalents.
First, there is a paucity of reported case law regarding patents. Thus,
there is little guidance for practicing patent attorneys. In fact, as noted by
Justice Zhipei, decisions made by the People's Court have no precedential
value, and cannot be cited by a later judge even if both cases have similar
facts, because judges may only cite laws and regulations. Accordingly,
"cases with similar facts may end up with different judgments by various
courts." 9
6 The necessity of uniform application of patent laws in China has
been recognized by the Chinese government, and an "Intellectual Property
Trial Division" has been established within the Supreme People's Court.
This Division is responsible for both hearing important intellectual property
cases and for instructing and supervising lower courts in intellectual
property matters.
97
Second, Chinese patent applications do not generate a "prosecution
history."98 Without such a record, competitors lack fundamental information
regarding what both the patentee and the Chinese Patent Office considered
the scope of the patented invention. Absent this information, prosecution
history estoppel and/or the doctrine of equivalents cannot be applied in a
given patent infringement case.
In patent infringement actions, the trial court is the Intermediate
People's Court in each of the municipalities, provinces, and coastal special
economic zones, as well as the Intermediate People's Court assigned by the
Supreme People's Court. The corresponding Higher People's Court has
94 Jiang Zhipei, Patent Litigation in China, 9 FED. CIR. B.J. 479, 484 (2000). Justice Zhipei is the
Deputy Chief Justice of the Intellectual Property Trial Chamber of the Supreme People's Court.
Justice Cheng Yongshun, New Development of Judicial Protection of Intellectual Property Rights
in China, Address at the Mainland-HKSAR Intellectual Property Symposium (2000) (on file with author).
Justice Yongshun is a justice of the Supreme People's Court.
96 Zhipei, supra note 94 at 483 n.16.
97 Justice Cheng Yongshun, Juridical Protection of Intellectual Property in China, 9 DuKE J. COMP.
& INT'L L. 267, 268 (1998).
9' Interview with Kan Zu, supra note 5.
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appellate jurisdiction in such cases.99 There is no single appellate court for
patent appeals in China analogous to the U.S. Court of Appeals for the
Federal Circuit.100
Under American patent law, the patentee always bears the burden of
proving infringement (literal or doctrine of equivalents) by a preponderance
of the evidence, regardless of the type of patent (e.g., product, process,
design) involved. 0 1 Conversely, China's patent law expressly shifts the
burden of proof when the infringement action involves a process patent for
the manufacture of a new product:
When any infringement dispute relates to a process patent for
the manufacture of a new product, any entity or individual
manufacturing the identical product shall furnish proof to the
effect that a different process is used in the manufacture of its
or his product.
10 2
It is believed that this "burden shifting" provision for process patents
is intended to overcome the disadvantages a patentee has in proving
infringing use of a patented process, in view of the lack of pretrial discovery
in patent litigation in China.'
0 3
This provision was decisive in Glaxo Group Ltd. v. South-West
Hecheng Pharmaceutical Factory.'°4  The multinational pharmaceutical
company Glaxo owned a Chinese invention patent for a process of
manufacturing the drug Ondansetron, which is used to prevent nausea and
vomiting caused by cancer chemotherapy. Glaxo learned of defendant
South-West's unauthorized manufacture of the drug and initially filed a
complaint with the local administrative authority for patent affairs,
requesting an investigation and handling of the matter.105 Subsequently,
99 Zhipei, supra note 94, at 481. The Supreme People's Court has assigned forty-three of the 400
Intermediate People's Courts to serve as courts of first instance in patent infringement cases. Yongshun,
supra note 97, at 271.
100 The U.S. Court of Appeals for the Federal Circuit was created in 1982 to handle all appeals of
patent cases from the United States District Courts as well as the U.S. Patent and Trademark Office. See 28
U.S.C. § 1295 (Supp. V 1999); 35 U.S.C. § 141 (Supp. V 1999).
1o1 See, e.g., Braun Inc. v. Dynamics Corp., 975 F.2d 815 (Fed. Cir. 1992).
02 CPL, supra note 47, art. 57. This provision was included in Article 60 of the prior patent law.
13 Interview with Kan Zu, supra note 5.
'4 Glaxo Group Ltd. v. S.W. Hecheng Pharm. Factory, (Chongqing Municipal No. 1 Intermediate
People's Court), described in Glaxo vs. South-West Pharmaceutical Factory, CHINA PATENT AGENT (H.K.)
LTD. (2001), at http://www.cpahkltd.com/Newsletter/Glaxo-SWPh.html.
105 Presumably this request was made pursuant to Article 60 of the prior patent law (now CPL Article
57), which permits the patentee the choice of either instituting legal proceedings for patent infringement in
the People's Court or requesting the administrative authority for patent affairs to handle the matter.
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Glaxo withdrew the administrative complaint and instituted a patent
infringement lawsuit in the Chongqing Municipal First Intermediate
People's Court,'0 6 seeking a cessation of infringement, a public apology, and
damages of RMB 320,000 yuan.
Upon court order, the defendant submitted details of the processes it
used to manufacture the drug to the court, and suggested that the court
conduct an on-site inspection and technical appraisal if deemed necessary.
The defendant also asserted that it did not infringe Glaxo's patent because
the defendant's processes were essentially different than Glaxo's patented
process. However, Glaxo contended that the information submitted by the
defendant to the court failed to establish that the submitted processes were
actually used by the defendant to manufacture its drug. Accordingly, Glaxo
requested the defendant to produce its regulatory documents previously
furnished to China's Ministry of Health to obtain approval for defendant's
manufacture of the drug, and to testify that the approved processes were the
methods of manufacture actually being used by the defendant. 7
The defendant refused to produce the requested regulatory
documents. 0 8 The court eventually ruled that the defendant's drug was
identical to the drug obtained from Glaxo's patented process.'0 9 In addition,
the court held that the defendant had failed to meet its statutory burden of
proving that the process it submitted to the court was the process actually
used by the defendant to make its drug product." 0 The court also ordered
the defendant to immediately cease its manufacture and sale of the drug, and
to make a public apology to the plaintiff."' The plaintiff was awarded RMB
320,000 yuan in compensatory damages, and the defendant was also ordered
to pay the litigation fee of RMB 15,363 yuan." 2 This was the first case
involving a foreign patentee in which the defendant lost due to its failure to
meet the statutory burden of proof." 1
3
1'6 The Intermediate People's Court of Chongquing is one of four Intermediate People's Courts
having jurisdiction over patent disputes pursuant to the approval of the Supreme People's Court. The other
three courts are the Dalian, Wenzou, and Fustian Intermediate People's Courts. See Zhipei, supra note 94,
at481 n.ll.
'07 See Glaxo vs. South-West Pharmaceutical Factory, supra note 104.
log Id.
109 Id.
110 Id.
111 Id.
112 Id.
113 Id.
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B. Patent Validity Issues
American patent law provides for administrative reexamination of
challenged patents.1 4 Similarly, under China's patent law, the PRB may
consider the validity of an issued patent and may declare the patent
invalid.' 15 Although the prior version of the law held that decisions of the
PRB were final, the most recent revisions permit the losing party to appeal
to the People's Court within three months of notification of the decision.
116
Significant differences exist between American and Chinese patent
law regarding the determination of patent validity in patent infringement
actions. In American patent cases, the accused infringer typically attacks the
patent's validity at trial before the same court or jury hearing the
infringement and damages issues1 17  It is also possible for the accused
infringer to seek to initiate a reexamination proceeding in the U.S. Patent
and Trademark Office after the patent litigation commences;' 1 8 however, the
trial court may use its discretion to determine whether to stay the patent
litigation until the validity issues are resolved by patent reexamination.
1 19
Under China's patent law a party may challenge an issued patent at
any time.120 Thus, an accused infringer seeking to delay the resolution of a
pending patent infringement action may request an invalidity determination
by the PRB. 12  However, such delays are more rare in the case of invention
patents than utility models or design patents because such patents have
already been substantively examined prior to being granted.
122
The interplay of the judicial and administrative processes in the patent
litigation context in China is illustrated by the case of Buhler A.G. v. Patent
Reexamination Board.123 The Swiss company Buhler obtained a Chinese
patent for an apparatus and method for milling cereals. Two Chinese
companies thereafter requested the PRB to invalidate the patent, and the
PRB subsequently found the patent invalid because the claimed invention
114 See 35 U.S.C. §§ 301-307 (1994 & Supp V 1999).
115 CPL, supra note 47, art. 46.
116 Id.
117 See discussion supra Part IH.A.
IS 35 U.S.C. § 302 (Supp. V 1999).
119 See, e.g., Gardco Mfg., Inc. v. Herst Lighting Co., 820 F.2d 1209 (Fed. Cir. 1987).
120 CPL, supra note 47, art. 45.
121 Interview with Kan Zu, supra note 5; see also Xintian, supra note 24, at 256-57.
122 See Xintian, supra note 24, at 256-57.
123 Buhler A.G. v. Patent Reexamination Board (Higher People's Court of Beijing Municipality),
described in Buhler A.G. vs. China Patent Reexamination Board, CHINA PATENT AGENT (H.K.) LTD., at
http://www.cpahkltd.com/Publications/Cases/Ebuhle.htm.
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lacked inventiveness. 124 Buhler then instituted an administrative proceeding
against the PRB's invalidity decision in the First Intermediate People's
Court of Beijing Municipality. 125  The First Intermediate People's Court
affirmed the invalidity judgment of the PRB, and Buhler then appealed to
the Beijing Higher People's Court. The Higher People's Court ultimately
affirmed the invalidity decisions of the PRB and the lower court.
126
C. Obtaining Injunctive Relief
Under American patent law, a patentee may obtain preliminary and
permanent injunctive relief to prevent the continued violation of patent
rights.127 China's patent law also provides that a preliminary injunction may
be obtained upon "reasonable evidence" of infringement or imminent
infringement, and that a delay in stopping such infringement is likely to
cause irreparable harm.1 28  Similarly, if an administrative patent action is
brought, the administrative patent authority is empowered to immediately
enjoin acts of patent infringement.'
2 9
D. Patent Damages
American patent damages must be "adequate to compensate [the
claimant] for the infringement, but in no event less than a reasonable royalty
for the use made of the invention by the infringer . ,,-30 The "adequate to
compensate" measure of damages is typically calculated as the patentee's
lost profits due to the infringing activities. 13' The court may enlarge
damages up to triple damages at its discretion, especially in cases of willful
infringement.
132
In China, patent damages are determined "according to the losses
suffered by the patentee or the profits gained by the infringer out of the
124 See discussion supra Part II.B.
125 For patent administrative disputes relating to the invalidation of a granted patent, the Beijing
Municipality First Intermediate Court has jurisdiction as the trial court because the Patent Reexamination
Board and the Chinese Patent Office reside in Beijing, and the Beijing Higher People's Court has appellate
jurisdiction in such cases. Zhipei, supra note 94, at 481.
126 See Buhler A.G. vs. China Patent Reexamination Board, supra note 123.
127 35 U.S.C. § 283 (Supp. V 1999).
128 CPL, supra note 47, art. 61.
' Id. art. 57.
135 35 U.S.C. § 284 (Supp. V 1999).
131 See, e.g., Del Mar Avionics, Inc. v. Quinton Instrument Co., 836 F.2d 1320, 1326 (Fed. Cir.
1987).
"' 35 U.S.C. § 284; see, e.g., TWM Mfg. Co. v. Dura Corp., 789 F.2d 895, 902 (Fed. Cir. 1986).
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infringement. 133 The new patent law has also been amended to provide that
where damages are difficult to quantify an acceptable alternative is "the
* appropriate times of the licensing royalties for licenses for the said
patent., 134 Given the unavailability of pretrial discovery, this provision will
presumably make it easier for the patentee to prove damages.
China's patent law also prohibits the "passing off' of patent rights. 135
If a person "passes off' another's patent (this means making a false
representation as to the ownership or authority to use another's patent
rights), the illegal income received shall be confiscated, and may be coupled
with a fine of up to three times the illegal income. 36 If there is no illegal
income, a fine of no more than RMB 50,000 yuan may be imposed. 137
Moreover, prosecution is mandated for criminal infringement.138 Similarly,
if a non-patented product or process is passed off as patented, a fine of no
more than RMB 50,000 yuan may be imposed.1 39 These acts of patent fraud
are outside the scope of American patent law.
E. Compulsory Licensing Issues
Another critical distinction between the patent laws of the United
States and China is that, unlike the United States, China permits compulsory
licensing of patents under certain circumstances despite the patentee's
refusal to otherwise grant a license. Conversely, under American patent law,
with certain narrow exceptions, the patentee has the absolute right to refuse
to license or otherwise permit others to practice the patented invention.140Under China's patent law:
Where any entity which is qualified to exploit the invention or
utility model has made requests for authorization from the
patentee of an invention or utility model to exploit its or his
patent on reasonable terms and such efforts have not been
successful within a reasonable period of time, the patent
administrative organ under the State Council may, upon the
13 CPL, supra note 47, art. 60.
134 id.
"' Id. art. 58.
36 Id.
137 Id.
138 Id.
"' Id. art. 59.
140 For example, in the interest of public health a court may deny injunctive relief in a patent case to
protect the public interest. See Rite-Hite Corp. v. Kelley Co., Inc., 56 F.3d 1538, 1547-48 (Fed. Cir. 1995).
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application of that entity, grant a compulsory license to exploit
the patent for invention or utility model.'
41
The party seeking the compulsory license bears the burden of proving
that it has been unable to obtain a license from the patentee on reasonable
terms. 142  The agency granting the c6mpulsory license must limit the
duration and scope of the license based upon the contents of the
application.143  The license may be terminated by the agency upon the
request of the patentee if the circumstances justifying the compulsory license
cease to exist and are unlikely to recur. 44 The compulsory licensee is not
entitled to an exclusive license, and may not sub-license the compulsory
license to others.145 The patentee is entitled to a "reasonable exploitation
fee" from the compulsory licensee, which is to be arrived at by consultation
between the patentee and compulsory licensee. 4 6 If the parties cannot reach
agreement regarding the fee, the patent administrative organ will determine
the fee.' 47 If the patentee is dissatisfied with either: (i) the granting of a
compulsory license; or (ii) the adjudicated fee, the patentee may institute
proceedings in the Beijing First Intermediate People's Court.' 48 A
compulsory license may also be granted by the administrative patent organ
"[w]here a national emergency or any extraordinary state of affairs occurs,
or where the public interest so requires ....
As a practical matter, American patentees in China cannot avoid
compulsory licenses. As one commentator has noted with respect to China's
compulsory licensing provisions, "foreign investors holding patent rights
should remain wary of obtaining patent rights in China solely for the
purpose of suppressing the use of the patented product or process,"
'150
because such suppression is likely to bolster the position of an entity seeking
a compulsory license.
141 CPL, supra note 47, art. 48.
142 Id. art. 51.
143 Id. art. 52.
144 rd.
141 Id. art. 53.
' Id. art. 54.
147 id.
141 Id. art. 55.
" Id. art. 49. Similarly, 28 U.S.C. § 1498(a) (Supp. V 1999) permits the U.S. government to "take"
a patented invention where warranted by public interest concerns and provide adequate compensation to the
patentee. See King Instruments Corp. v. Perego, 65 F.3d 941, 950 (Fed. Cir. 1995).
150 Harrington, supra note 2, at 369.
MARCH 2002
338 PACIFIC RIM LAW & POLICY JOURNAL VOL. 11 No. 2
V. CONCLUSION
China's patent law is generally compatible with its American
counterpart. However, there are differences such as China's compulsory
licensing scheme and its lack of case law. The latter is particularly
troubling, because a lack of precedent invariably leads to inconsistent
application of legal principles and a concomitant lack of predictability.
Without such predictability, lawyers will continue to have trouble advising
their clients regarding patent law matters in China. One possible solution
might be to have the major state-sanctioned patent law firms in China
prepare a collective "reporter" of patent case law on an ongoing basis. This
would greatly aid practicing patent lawyers both in China and abroad.
